ES2086005T3 - Derivados de eteres de ciclopentano, procedimiento para su preparacion y su utilizacion farmaceutica. - Google Patents

Derivados de eteres de ciclopentano, procedimiento para su preparacion y su utilizacion farmaceutica.

Info

Publication number
ES2086005T3
ES2086005T3 ES91920342T ES91920342T ES2086005T3 ES 2086005 T3 ES2086005 T3 ES 2086005T3 ES 91920342 T ES91920342 T ES 91920342T ES 91920342 T ES91920342 T ES 91920342T ES 2086005 T3 ES2086005 T3 ES 2086005T3
Authority
ES
Spain
Prior art keywords
pct
cyclopentane
derivatives
ether
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920342T
Other languages
English (en)
Inventor
Hartmut Rehwinkel
Ulrich Klar
Helmut Vorbruggen
Karl-Heinz Thierauch
Peter Verhallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2086005T3 publication Critical patent/ES2086005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)

Abstract

LA INVENCION CONCIERNE A DERIVADOS DE ETER DE CICLOPENTANO, DE FORMULA (I), CUYAS SALES CON BASES TOLERABLES FISIOLOGICAMENTE, ASI COMO LOS O, (BETA) Y P COMO COMPUESTOS DE FORMULA (I) ENCAPSULADOS CON LIPOSOMAS, EL PROCEDIMIENTO PARA SU OBTENCION Y SU UTILIZACION FARMACOLOGICA.
ES91920342T 1990-11-23 1991-11-23 Derivados de eteres de ciclopentano, procedimiento para su preparacion y su utilizacion farmaceutica. Expired - Lifetime ES2086005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037941A DE4037941A1 (de) 1990-11-23 1990-11-23 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
ES2086005T3 true ES2086005T3 (es) 1996-06-16

Family

ID=6419130

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920342T Expired - Lifetime ES2086005T3 (es) 1990-11-23 1991-11-23 Derivados de eteres de ciclopentano, procedimiento para su preparacion y su utilizacion farmaceutica.

Country Status (14)

Country Link
US (1) US5625067A (es)
EP (1) EP0558570B1 (es)
JP (1) JPH06506439A (es)
AT (1) ATE132854T1 (es)
AU (1) AU667294B2 (es)
CA (1) CA2096848A1 (es)
DE (2) DE4037941A1 (es)
DK (1) DK0558570T3 (es)
ES (1) ES2086005T3 (es)
GR (1) GR3019568T3 (es)
HU (1) HUT64306A (es)
IE (1) IE73875B1 (es)
PT (1) PT99586B (es)
WO (1) WO1992009573A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
JPWO2001094309A1 (ja) 2000-06-02 2004-02-05 塩野義製薬株式会社 Pgd2/txa2両受容体拮抗性医薬組成物
EP1338594A4 (en) 2000-11-01 2004-06-16 Shionogi & Co PGD2 RECEPTOR ANTAGONIST PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
PT99586A (pt) 1992-10-30
PT99586B (pt) 1999-05-31
WO1992009573A2 (de) 1992-06-11
JPH06506439A (ja) 1994-07-21
DK0558570T3 (da) 1996-06-03
DE59107261D1 (de) 1996-02-22
AU8946391A (en) 1992-06-25
AU667294B2 (en) 1996-03-21
ATE132854T1 (de) 1996-01-15
HU9301497D0 (en) 1993-09-28
EP0558570A1 (en) 1993-09-08
IE73875B1 (en) 1997-07-02
CA2096848A1 (en) 1992-05-24
DE4037941A1 (de) 1992-05-27
US5625067A (en) 1997-04-29
EP0558570B1 (de) 1996-01-10
IE914062A1 (en) 1992-06-03
WO1992009573A3 (de) 1994-01-06
GR3019568T3 (en) 1996-07-31
HUT64306A (en) 1993-12-28

Similar Documents

Publication Publication Date Title
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
SE9904505D0 (sv) Novel compounds
ATE316083T1 (de) Adamantanderivate
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
IT1311923B1 (it) Composti farmaceutici.
GT199900019A (es) Formulas farmaceuticamente estables de solucion de oxaliplatino.
HUP9600876A2 (hu) Benzonitril- és -fluorid-származékok, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
BR9507489A (pt) Derivados tropano sua preparacão e uso
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR0213481A (pt) Sondas
PT98464A (pt) Processo para a preparacao de derivados de ciclopentano e de composicoes farmaceuticas que os contem
DE59203771D1 (de) 9-substituierte bicyclo [3.3.0]octan-derivate verwendbar als txa2-antagonisten.
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0211425A (pt) Método para a preparação de compostos, e, uso de uma composição
PT99468A (pt) Processo para a preparacao de compostos cefem 7-actil-3-(carbamoiloxi substituido) com propriedades antibacterianas
YU31995A (sh) Benzotiofeni glikopiranozida, postupak za njihovo dobijanje i njihova farmaceutska formulacija
DK0558570T3 (da) Cyklopentanetherderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
EA200201024A1 (ru) Фармацевтические композиции, содержащие олигосахариды, и их получение
NO950177D0 (no) Farmakologisk aktive erivater
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
BR0109252A (pt) Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição
ES2082202T3 (es) Derivados de biciclo(3.3.0)octano, procedimiento para su preparacion y su utilizacion farmaceutica.
BG105178A (bg) Нови 2,3,3а,4,9,9а-хексахидро-8-хидрокси-1н-бенз/f/индоли, метод за получаването им и приложението им като лекарствени средства

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558570

Country of ref document: ES